The COVID-19 pandemic has disrupted the routine of in-person events, the need for sharing information and building key supplier connections for bio/pharmaceutical development and manufacturing has never been greater.

 The 2020 Bio/Pharma Virtual Congress event will connect bio/pharma formulation, development, manufacturing, and quality experts with a full day of technical presentations, panel discussions, interviews, and vendor meetings, through an interactive portal. 


 This online event will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. 

8:30 am to 4:00 pm ET

November 11, 2020

Your Computer

FORMULATION

Topics included in this session are drug development, drug delivery, APIs, excipients, formulation trends, modified release, injectable drug formulation, and more.

DRUG DOSAGE FORM TRENDS

Topics include in this session are vaccines, biologics, solid dosage drugs, controlled release, cell and gene therapies, and more.

MANUFACTURING

Topics included in this session are manufacturing strategies, process analytical technology, process and operational intelligence, data integrity, predictive maintenance, scale up, fluid-bed coating, and more

Four Interactive Tracks

DOWNLOAD AGENDA

BIO/PHARMA
INDUSTRY CHALLENGES

Topics included in this sessions are drug quality, regulatory inspections, COVID-19 pandemic impact, good manufacturing practices, regulated documents, and more

Emerging technologies and processes that impact, enable, and advance bio/pharmaceutical development and manufacturing will be explored in Editors’ Series panel discussions and technical session presented by industry experts in four topic areas:

The COVID-19 pandemic has disrupted the routine of in-person events, the need for sharing information and building key supplier connections for bio/pharmaceutical development and manufacturing has never been greater.

 The 2020 Bio/Pharma Virtual Congress event will connect bio/pharma formulation, development, manufacturing, and quality experts with a full day of technical presentations, panel discussions, interviews, and vendor meetings, through an interactive portal. 


 This online event will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. 

Keynote Panel Discussions

The bio/pharma industry has demonstrated its R&D capabilities by accelerating development of vaccines and therapeutics to combat COVID-19. At the same time the industry faced intense scrutiny and political pressure. What are the short-, medium-, and long-term implications for bio/pharma development and manufacturing? Representatives of PhRMA, BIO, and other industry organizations will discuss and debate crucial business, regulatory, science-based issues facing the industry.

James Mayne, Ph.D.
Vice President
Science & Regulatory Advocacy
PhRMA 

Phyllis Arthur
Vice President for Infectious Diseases and Diagnostics Policy
Biotechnology Innovation Organization

Supporting Sponsor:

Sponsors:

Schedule at a Glance

Wednesday, November 11th

8:30 a.m. _____________________________________________________________ 
9:00 a.m. 
______________________________________________________________
9:45 a.m_________________________________________________

10:00 a.m._______________________________________________________
11:00 a.m.
_______________________________________________ 
11:30 a.m.
_______________________________________________________ 
12:30 p.m.
_______________________________________________ 
1:30 p.m._______________________________________________________
2:30 p.m._________________________________________________
3:00 p.m._______________________________________________________
4:00 p.m.________________________________________________________________


Registration Opens 
 Keynote Speaker

Networking Break in Exhibit Hall  
Track Breakout Sessions 
Networking Break in Exhibit Hall 
Track Breakout Sessions 
Networking Break in Exhibit Hall 
Track Breakout Sessions
Networking Break in Exhibit Hall
Track Breakout Sessions 
Event Close

Schedule at a Glance

Wednesday, November 11th

Supporting Sponsor:

Featured Speakers

REGISTER NOWREGISTER NOW

November 11, 2020

8:30 am to 4:00 pm ET

Your Computer

Sponsors:

Nathan Dormer, Ph.D.
Director
Drug Product Development
Adare

Daniel Kuntz
Associate Principal Engineer
Lonza Pharma & Biotech

Erin Hyde
Scientist II, Product Development
Lonza Pharma & Biotech

Nathan Dormer, Ph.D.
Drug Product Development
Adare

Bikash Chatterjee
CEO
Pharmatech Associates

Amit Samel
Life Sciences Technical Solution Consultant 
Honeywell 

Pamela Docherty
Life Sciences Industry Manager
Siemens

Kirsten Schaub
AVP- Commercial Sales, Healthcare and Life Sciences
DocuSign

Christina Wong 
 Marketing
Regulated Industries
 DocuSign
 

Ellen Reilly
Vice President
Global Partners
IQVIA

David R. Schoneker
President/Owner/Consultant
Black Diamond Regulatory Consulting, LLC

Amor Dos
General Manager of the Pharma Team Automation Products Group
Applied Materials

Bob Lenich
Global Life Sciences Director
Emerson

Gilberto Dalmaso
Technical Science Director
 Europe & Asia
Veltek Associates Inc.

Nigel Langley
Global Technology Director
BASF Corporation Pharma Solution

Eric Langer
Managing Partner
BioPlan Associates, Inc

Gilberto Dalmaso
Technical Science Director
 Europe & Asia
Veltek Associates Inc.

Joe Zeleznik
Technical Product Manager
IMCD US

Tiffany Barnes
Life Sciences Technical Solution Consultant
Honeywell

Featured Speakers

REGISTER NOW
REGISTER NOW

Four Interactive Tracks

FORMULATION

Topics included in this session are drug development, drug delivery, APIs, excipients, formulation trends, modified release, injectable drug formulation, and more.

MANUFACTURING

Topics included in this session are manufacturing strategies, process analytical technology, process and operational intelligence, data integrity, predictive maintenance, scale up, 
fluid-bed coating, and more

DRUG DOSAGE FORM TRENDS

Topics include in this session are vaccines, biologics, solid dosage drugs, controlled release, cell and gene therapies, and more.

BIOPHARMA INDUSTRY CHALLENGES

Topics included in this sessions are drug quality, regulatory inspections, COVID-19 pandemic impact, good manufacturing practices, regulated documents, and more

8:30 a.m. _________________________ 
9:00 a.m. _
__________________________
9:45 a.m. __________

10:00 a.m.__________________
11:00 a.m.
__________ 
11:30 a.m.
___________________ 
12:30 p.m.
__________ 
1:30 p.m.___________________
2:30 p.m.___________
3:00 p.m.___________________
4:00 p.m._________________________________

Registration Opens 
 Keynote Speaker

Networking Break in Exhibit Hall 
Track Breakout Sessions
Networking Break in Exhibit Hall
Track Breakout Sessions 

Networking Break in Exhibit Hall 
Track Breakout Sessions
Networking Break in Exhibit Hall
Track Breakout Sessions 
Event Close
 

REGISTER NOWREGISTER NOWDOWNLOAD AGENDA

Emerging technologies and processes that impact, enable, and advance bio/pharmaceutical development and manufacturing will be explored in Editors’ Series panel discussions and technical session presented by industry experts in four topic areas:

Amit Samel
Life Sciences Technical Solution Consultant
Honeywell

Bikash Chatterjee
CEO
Pharmatech Associates

Pamela Docherty
Life Sciences Industry Manager
Siemens

Ellen Reilly
Vice President
Global Partners
IQVIA

Kirsten Schaub
AVP - Commercial Sales, Healthcare and Life Sciences
DocuSign


Keynote Panel Discussion

The bio/pharma industry has demonstrated its R&D capabilities by accelerating development of vaccines and therapeutics to combat COVID-19. At the same time the industry faced intense scrutiny and political pressure. What are the short-, medium-, and long-term implications for bio/pharma development and manufacturing? Representatives of PhRMA, BIO, and other industry organizations will discuss and debate crucial business, regulatory, science-based issues facing the industry.


James Mayne, Ph.D.
Vice President
Science & Regulatory Advocacy
PhRMA 

Phyllis Arthur
Vice President for Infectious Diseases and Diagnostics Policy
Biotechnology Innovation Organization

Christina S. Wong
Marketing- Regulated Industries
DocuSign

Erin Hyde
Scientist II, Product Development
Lonza Pharma & Biotech

Amor Dos
General Manager of the Pharma Team Automation Products Group
Applied Materials

Bob Lenich
Global Life Sciences Director
Emerson

Daniel Kuntz
Associate Principal Engineer
Lonza Pharma & Biotech

David R. Schoneker
President/Owner/Consultant
Black Diamond Regulatory Consulting, LLC

Gilberto Dalmaso
Technical Science Director
 Europe & Asia
Veltek Associates Inc.

Eric Langer
Managing Partner
BioPlan Associates, Inc

Nigel Langley
Global Technology Director
BASF Corporation Pharma Solutions

Tiffany Barnes
Life Sciences Technical Solution Consultant
Honeywell

Joe Zeleznik
Technical Product Manager
IMCD US